Skip to main content
Caplight Logo









Base Therapeutics

Base Therapeutics

Private
ShanghaiHealthcare & Life Scienceshttps://www.basetherapeutics.com/

Last Round

Series A

Extension

Sep 12, 2024

Total Funding Raised

$34.5M

Company Overview

Base Therapeutics is a biotechnology company specializing in gene editing and cell-based therapies for the treatment of cancer and genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

base editinggene editingcell therapyprime editingCRISPR alternativeNK cell therapybiotech licensingprecision medicineoff-the-shelf therapygene therapynext-gen gene editingbiopharmaceutical partnershipGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Base Therapeutics Comparables

Compare Base Therapeutics with similar companies based on industry and business-model similarity.

Base Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
YolTech Therapeutics
80%
Beam Therapeutics
78%
Prime Medicine
78%

Base Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionSep 12, 2024
Series AJan 18, 2023

Base Therapeutics Investors

Notable investors and investment history

Base Therapeutics investors
InvestorRounds
HighLight CapitalSeries A
Gobi PartnersSeed
Spark VenturesSeries A
Baidu VenturesSeries A
Gobi Partners GBASeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 12, 2024

    Led by aef-greater-bay-area-fund with participation from Gobi Partners GBA.

  • Jan 18, 2023

    $20M round led by Great Eagle Holdings Limited.

Base Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Base Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Base Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Year Founded2021
Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?